Main container

Nanotechnology-based Platforms for the improvEment of therapeutic strateGies in soft tissue sArcoma and melanoma leSiOns - Piattaforme su base nanotecnologica per il miglioramento delle strategie terapeutiche nelle lesioni di sarcoma dei tessuti molli ...

Title
Nanotechnology-based Platforms for the improvEment of therapeutic strateGies in soft tissue sArcoma and melanoma leSiOns - Piattaforme su base nanotecnologica per il miglioramento delle strategie terapeutiche nelle lesioni di sarcoma dei tessuti molli ...
Code
IRST B 141_PEGASO
Type
Sperimentale
Start Year
2023
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
26/09/2023 09:54